Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$19,233,148
+$710,952 QoQ
Shares Held
75,730
-0.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#753
of 4,664 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pallas Capital Advisors LLC holds $57,599,993 across 10 Drug Manufacturers - General names. JNJ ranks #1 (33.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
75,730 | $19,233,148 | |
| 2 | LLY |
ELI LILLY & Co
|
9,795 | $11,748,417 | |
| 3 | MRK |
Merck & Co., Inc.
|
62,572 | $8,040,502 | |
| 4 | ABBV |
AbbVie Inc.
|
26,085 | $6,564,029 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
77,353 | $4,457,079 | |
| 6 | BIIB |
Biogen Inc.
|
12,859 | $2,778,315 | |
| 7 | PFE |
Pfizer Inc
|
75,558 | $1,819,436 | |
| 8 | AMGN |
Amgen Inc
|
4,792 | $1,735,279 |
All Filings in JNJ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,233,148 | 75,730 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $18,522,196 | 75,774 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $17,044,608 | 82,361 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $16,394,465 | 88,418 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $13,444,596 | 88,017 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $15,284,477 | 92,164 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $7,242,280 | 50,078 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $12,577,476 | 77,610 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $11,228,888 | 76,826 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $11,615,100 | 73,425 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $9,489,196 | 60,541 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $8,643,190 | 55,494 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $11,641,683 | 70,334 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $10,396,005 | 67,071 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $11,202,789 | 63,418 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $10,418,284 | 63,775 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $10,858,109 | 61,169 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $11,700,192 | 66,017 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $12,107,479 | 70,775 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $11,117,498 | 68,839 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,979,181 | 48,435 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $6,822,990 | 41,515 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||